login
  Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

Boston Scientific launches Ingenio and Advantio family of pacemakers in Europe


Wednesday, 11 Apr 2012 10:29

Boston Scientific has announced CE mark approval and European market launch of its Ingenio and Advantio pacemakers and  Invive cardiac resynchronisation therapy pacemakers (CRT-P). Marc Burban performed one of the first implants of the Ingenio on the first week of April at the Nouvelles Cliniques Nantaises in Nantes, France. 


“The Ingenio device enables physicians to treat pacemaker patients with an advanced and comprehensive set of therapies,” said Burban. “The new RightRate pacing is easy to optimise and is designed to provide needed heart rates for patients to help them feel less fatigued during physical activity.”

“The Ingenio family of pacemakers represents a significant investment in long-term innovation for pacing technologies and defines a new era of pacing for our company,” said Joe Fitzgerald, senior vice president and president of the Boston Scientific Cardiac Rhythm Management group. “In addition, we expect to launch a series of devices with expanded capabilities, that would include remote monitoring, advanced heart failure diagnostics and compatibility with magnetic resonance imaging systems - all designed to provide innovative new features for patient health and well-being.”


The Ingenio and Advantio pacemakers feature RightRate pacing technology designed to treat chronotropic incompetence. RightRate employs Boston Scientific’s minute ventilation sensor, the only sensor clinically proven to restore chronotropic competence, and adds programming options to promote ease of use and in-clinic time savings.


The Ingenio and Advantio pacemakers are currently under review by the US Food and Drug Administration (FDA), and are currently not available for sale in the United States.




Add New Comment

Most popular


Non-invasive mapping prior to ablation may be an effective strategy for persistent atrial fibrillation
Tuesday, 16 Dec 2014
Preliminary data from the AFACART study have shown encouraging results when treating persistent atrial fibrillation with non-invasive mapping followed by pulmonary vein isolation and/or linear ... Non-invasive mapping prior to ablation may be an effective strategy for persistent atrial fibrillation

Patients with standard cardiac devices can undergo non-thoracic MRI scans, registry finds
Tuesday, 16 Dec 2014
Results of the MagnaSafe registry indicate that patients with standard pacemakers or implantable cardioverter defibrillators (ICDs)—which are not magnetic resonance imaging (MRI) conditional—can ... Patients with standard cardiac devices can undergo non-thoracic MRI scans, registry finds

Philips launches DoseWise Portal radiation dose management software
Monday, 01 Dec 2014
Royal Philips has introduced the DoseWise Portal, a comprehensive radiation dose management software solution aimed at managing radiation exposure risk to patients and their caregivers. Philips launches DoseWise Portal radiation dose management software

Features


Non-invasive identification of drivers in persistent AF
Monday, 12 Jan 2015
Research by Haïssaguerre et al has demonstrated that persistent atrial fibrillation, particularly in early months, is maintained by drivers clustered in few regions. Non-invasive identification of drivers in persistent AF

Danish data question preparticipation screening for sport-related sudden cardiac death
Monday, 29 Dec 2014
Bjarke Risgaard and Jacob Tfelt-Hansen discuss the new data that questions the implementation of a screening programme of all competitive athletes to avoid sports related sudden cardiac death. Danish data question preparticipation screening for sport-related sudden cardiac death

Profiles


Massimo Santini
Friday, 10 Oct 2014
Massimo Santini performed the first fulguration of the atrioventricular node of resistant ... Massimo Santini

Nick Linker
Monday, 14 Jul 2014
Nick Linker is president-elect of the British Heart Rhythm Society (BHRS) and programme director of ... Nick Linker

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions